Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve

Figure 3 Wound bed IIa and IIb. A and B: Burn before Nexobrid^® treatment; C and D: After Nexobrid^® treatment with two different wound bed. Type IIa and Type IIb, sparse pattern of larger diameter bleeders (no shades, white colour) that it is depressed in relation to the surrounding healthy skin, or the own bed surface skin burn (Deep partial thickness burn); E and F: Autografting after two weeks; G and H: Final outcome after 6 mo.